AbbVie, the makers of Botox, raised its 2025 profit forecast on Thursday, after beating Wall Street estimates for ...

Early into Trump’s second term as US president, the CEO of energy infrastructure company Hut 8 Asher Genoot and Hut 8 chief ...

While Bristol-Myers Squibb has lagged behind the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Having nearly tripled in price from the April lows, the stock received a number of modest price target hikes, but no ratings ...

Bay's stock soared after upbeat Q2 earnings amidst the exciting earnings season. Analysts have mixed ratings and outlook for ...